Moderna Inc traded at $173.25 this Friday February 3rd, decreasing $3.10 or 1.76 percent since the previous trading session. Looking back, over the last four weeks, Moderna Inc lost 2.32 percent. Over the last 12 months, its price rose by 6.28 percent. Looking ahead, we forecast Moderna Inc to be priced at 183.14 by the end of this quarter and at 165.70 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
173.25
Daily Change
-1.76%
Yearly
6.28%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 19.83 -0.08 -0.40% -15.97%
Acorda Therapeutics 0.98 0.01 0.84% -48.10%
Agios Pharmaceuticals 30.20 0.02 0.07% 5.08%
Alnylam Pharmaceuticals 233.37 3.62 1.58% 60.48%
Amgen 245.17 -1.36 -0.55% 10.38%
Arrowhead Research 36.74 -0.27 -0.73% -26.15%
Biogen 283.63 -3.89 -1.35% 28.03%
Bluebird Bio 6.65 0.02 0.30% -2.35%
BioMarin Pharmaceutical 112.20 -0.64 -0.57% 26.59%
Esperion Therapeutics 5.90 -0.02 -0.34% 65.27%
Gilead Sciences 84.50 3.11 3.82% 32.24%
GlaxoSmithKline 1,434.20 6.80 0.48% -12.28%
Intercept Pharmaceuticals 19.02 -0.13 -0.68% 24.23%
Incyte Corp 83.61 -0.88 -1.04% 15.02%
Ionis Pharmaceuticals 40.92 -0.28 -0.68% 29.90%
Mirati Therapeutics 52.57 -1.69 -3.11% -56.16%
Puma Biotechnology 4.46 0.09 2.06% 84.30%
Ultragenyx Pharmaceutical 45.73 -1.61 -3.40% -33.36%
Regeneron Pharmaceuticals 783.13 31.93 4.25% 25.71%
Seattle Genetics 138.00 -1.43 -1.03% 0.05%
Sangamo BioSciences 3.51 -0.16 -4.36% -36.87%
Sarepta Therapeutics 119.00 -1.25 -1.04% 62.77%
United Therapeutics 252.80 -6.68 -2.57% 25.40%
Vertex Pharmaceuticals 301.02 -2.76 -0.91% 24.41%

Indexes Price Day Year
USNDX 12573 -229.78 -1.79% -14.43%
US500 4136 -43.28 -1.04% -8.09%

Moderna Inc
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.